Cargando…
Impact of COVID-19 on Neuropsychiatric Disorders
Since the Coronavirus disease 2019 (COVID-19) pandemic, caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), many studies have shown that besides common COVID-19 symptoms, patients may develop various neuropsychiatric conditions including anxiety, mood disorders, psychosis, neurod...
Autores principales: | Zia, Niloufar, Ravanfar, Parsa, Allahdadian, Sepideh, Ghasemi, Mehdi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9456667/ https://www.ncbi.nlm.nih.gov/pubmed/36079143 http://dx.doi.org/10.3390/jcm11175213 |
Ejemplares similares
-
The Role of Tryptophan Metabolites in Neuropsychiatric Disorders
por: Davidson, Majid, et al.
Publicado: (2022) -
Neuropsychiatric disorders and COVID-19
por: Charlton, Elizabeth, et al.
Publicado: (2021) -
Neuropsychiatric disorders and COVID-19
por: Finsterer, Josef
Publicado: (2021) -
Neuropsychiatric disorders and COVID-19
por: Burchill, Ella, et al.
Publicado: (2021) -
COVID-19 impacts the expression of molecular markers associated with neuropsychiatric disorders
por: Quincozes-Santos, André, et al.
Publicado: (2020)